<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-11-01" modified="2020-10-07" version="241">
<accession>P42224</accession>
<accession>A8K989</accession>
<accession>B2RCA0</accession>
<accession>D2KFR8</accession>
<accession>D3DPI7</accession>
<accession>Q53S88</accession>
<accession>Q53XW4</accession>
<accession>Q68D00</accession>
<accession>Q9UDL5</accession>
<name>STAT1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Signal transducer and activator of transcription 1-alpha/beta</fullName>
</recommendedName>
<alternativeName>
<fullName>Transcription factor ISGF-3 components p91/p84</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">STAT1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Proc. Natl. Acad. Sci. U.S.A." volume="89" first="7836" last="7839">
<title>Proteins of transcription factor ISGF-3: one gene encodes the 91- and 84-kDa ISGF-3 proteins that are activated by interferon alpha.</title>
<authorList>
<person name="Schindler C."/>
<person name="Fu X.-Y."/>
<person name="Improta T."/>
<person name="Aebersold R."/>
<person name="Darnell J.E. Jr."/>
</authorList>
<dbReference type="PubMed" id="1502203"/>
<dbReference type="DOI" id="10.1073/pnas.89.16.7836"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA)</scope>
<scope>PROTEIN SEQUENCE OF 514-524; 654-660 AND 667-672</scope>
</reference>
<reference key="2">
<citation type="submission" date="2009-11" db="EMBL/GenBank/DDBJ databases">
<title>Novel STAT1 alleles in a patient with impaired resistance to mycobacteria.</title>
<authorList>
<person name="Kristensen I."/>
<person name="Veirum J.E."/>
<person name="Moeller B.K."/>
<person name="Christiansen M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA)</scope>
</reference>
<reference key="3">
<citation type="submission" date="2004-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA)</scope>
<source>
<tissue>Placenta</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA)</scope>
</reference>
<reference key="6">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BETA)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BETA)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1995" name="Nucleic Acids Res." volume="23" first="459" last="463">
<title>The genomic structure of the STAT genes: multiple exons in coincident sites in Stat1 and Stat2.</title>
<authorList>
<person name="Yan R."/>
<person name="Qureshi S."/>
<person name="Zhong Z."/>
<person name="Wen Z."/>
<person name="Darnell J.E. Jr."/>
</authorList>
<dbReference type="PubMed" id="7885841"/>
<dbReference type="DOI" id="10.1093/nar/23.3.459"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1992" name="Cell" volume="70" first="323" last="335">
<title>A transcription factor with SH2 and SH3 domains is directly activated by an interferon alpha-induced cytoplasmic protein tyrosine kinase(s).</title>
<authorList>
<person name="Fu X.Y."/>
</authorList>
<dbReference type="PubMed" id="1638633"/>
<dbReference type="DOI" id="10.1016/0092-8674(92)90106-m"/>
</citation>
<scope>PHOSPHORYLATION IN RESPONSE TO IFN-ALPHA</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1995" name="Cell" volume="82" first="241" last="250">
<title>Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation.</title>
<authorList>
<person name="Wen Z."/>
<person name="Zhong Z."/>
<person name="Darnell J.E. Jr."/>
</authorList>
<dbReference type="PubMed" id="7543024"/>
<dbReference type="DOI" id="10.1016/0092-8674(95)90311-9"/>
</citation>
<scope>PHOSPHORYLATION AT SER-727</scope>
<scope>MUTAGENESIS</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="20775" last="20780">
<title>Phosphorylation and activation of the DNA binding activity of purified Stat1 by the Janus protein-tyrosine kinases and the epidermal growth factor receptor.</title>
<authorList>
<person name="Quelle F.W."/>
<person name="Thierfelder W."/>
<person name="Witthuhn B.A."/>
<person name="Tang B."/>
<person name="Cohen S."/>
<person name="Ihle J.N."/>
</authorList>
<dbReference type="PubMed" id="7657660"/>
<dbReference type="DOI" id="10.1074/jbc.270.35.20775"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-701</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1996" name="EMBO J." volume="15" first="1075" last="1084">
<title>The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-alpha signals.</title>
<authorList>
<person name="Gupta S."/>
<person name="Yan H."/>
<person name="Wong L.H."/>
<person name="Ralph S."/>
<person name="Krolewski J."/>
<person name="Schindler C."/>
</authorList>
<dbReference type="PubMed" id="8605877"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1996.tb00445.x"/>
</citation>
<scope>TYROSINE PHOSPHORYLATION</scope>
<scope>HETERODIMERIZATION</scope>
<scope>DNA-BINDING</scope>
<scope>MUTAGENESIS</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1997" name="Mol. Cell. Biol." volume="17" first="2048" last="2056">
<title>Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling.</title>
<authorList>
<person name="Li X."/>
<person name="Leung S."/>
<person name="Kerr I.M."/>
<person name="Stark G.R."/>
</authorList>
<dbReference type="PubMed" id="9121453"/>
<dbReference type="DOI" id="10.1128/mcb.17.4.2048"/>
</citation>
<scope>INTERACTION WITH IFNAR1 AND IFNAR2</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="10626" last="10631">
<title>Inhibition of Stat1-mediated gene activation by PIAS1.</title>
<authorList>
<person name="Liu B."/>
<person name="Liao J."/>
<person name="Rao X."/>
<person name="Kushner S.A."/>
<person name="Chung C.D."/>
<person name="Chang D.D."/>
<person name="Shuai K."/>
</authorList>
<dbReference type="PubMed" id="9724754"/>
<dbReference type="DOI" id="10.1073/pnas.95.18.10626"/>
</citation>
<scope>INTERACTION WITH PIAS1</scope>
<scope>FUNCTION</scope>
<source>
<tissue>B-cell</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="Cell" volume="96" first="121" last="130">
<title>Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling.</title>
<authorList>
<person name="Zhu M.-H."/>
<person name="John S."/>
<person name="Berg M."/>
<person name="Leonard W.J."/>
</authorList>
<dbReference type="PubMed" id="9989503"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)80965-4"/>
</citation>
<scope>INTERACTION WITH NMI</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH NMI AND CREBBP</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1999" name="Intervirology" volume="42" first="325" last="330">
<title>Viral inhibition of interferon signal transduction.</title>
<authorList>
<person name="Cebulla C.M."/>
<person name="Miller D.M."/>
<person name="Sedmak D.D."/>
</authorList>
<dbReference type="PubMed" id="10702714"/>
<dbReference type="DOI" id="10.1159/000053968"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="Genes Cells" volume="6" first="545" last="557">
<title>Sendai virus C protein physically associates with Stat1.</title>
<authorList>
<person name="Takeuchi K."/>
<person name="Komatsu T."/>
<person name="Yokoo J."/>
<person name="Kato A."/>
<person name="Shioda T."/>
<person name="Nagai Y."/>
<person name="Gotoh B."/>
</authorList>
<dbReference type="PubMed" id="11442634"/>
<dbReference type="DOI" id="10.1046/j.1365-2443.2001.00442.x"/>
</citation>
<scope>INTERACTION WITH SENDAI VIRUS C PROTEIN</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="19512" last="19523">
<title>Focal adhesion kinase activates Stat1 in integrin-mediated cell migration and adhesion.</title>
<authorList>
<person name="Xie B."/>
<person name="Zhao J."/>
<person name="Kitagawa M."/>
<person name="Durbin J."/>
<person name="Madri J.A."/>
<person name="Guan J.L."/>
<person name="Fu X.Y."/>
</authorList>
<dbReference type="PubMed" id="11278462"/>
<dbReference type="DOI" id="10.1074/jbc.m009063200"/>
</citation>
<scope>INTERACTION WITH PTK2/FAK1</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="5662" last="5668">
<title>Identification of a nuclear Stat1 protein tyrosine phosphatase.</title>
<authorList>
<person name="ten Hoeve J."/>
<person name="de Jesus Ibarra-Sanchez M."/>
<person name="Fu Y."/>
<person name="Zhu W."/>
<person name="Tremblay M."/>
<person name="David M."/>
<person name="Shuai K."/>
</authorList>
<dbReference type="PubMed" id="12138178"/>
<dbReference type="DOI" id="10.1128/mcb.22.16.5662-5668.2002"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>DEPHOSPHORYLATION BY PTPN2</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="Blood" volume="102" first="3311" last="3313">
<title>PIAS proteins promote SUMO-1 conjugation to STAT1.</title>
<authorList>
<person name="Ungureanu D."/>
<person name="Vanhatupa S."/>
<person name="Kotaja N."/>
<person name="Yang J."/>
<person name="Aittomaeki S."/>
<person name="Jaenne O.A."/>
<person name="Palvimo J.J."/>
<person name="Silvennoinen O."/>
</authorList>
<dbReference type="PubMed" id="12855578"/>
<dbReference type="DOI" id="10.1182/blood-2002-12-3816"/>
</citation>
<scope>SUMOYLATION AT LYS-703</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-703</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="30091" last="30097">
<title>SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation.</title>
<authorList>
<person name="Rogers R.S."/>
<person name="Horvath C.M."/>
<person name="Matunis M.J."/>
</authorList>
<dbReference type="PubMed" id="12764129"/>
<dbReference type="DOI" id="10.1074/jbc.m301344200"/>
</citation>
<scope>SUMOYLATION AT LYS-703</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-110 AND LYS-703</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="Cell. Mol. Life Sci." volume="61" first="2535" last="2548">
<title>Signal transduction via the stem cell factor receptor/c-Kit.</title>
<authorList>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="15526160"/>
<dbReference type="DOI" id="10.1007/s00018-004-4189-6"/>
</citation>
<scope>REVIEW ON ROLE IN KIT SIGNALING</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="45603" last="45612">
<title>Protein kinase Cdelta regulates apoptosis via activation of STAT1.</title>
<authorList>
<person name="DeVries T.A."/>
<person name="Kalkofen R.L."/>
<person name="Matassa A.A."/>
<person name="Reyland M.E."/>
</authorList>
<dbReference type="PubMed" id="15322115"/>
<dbReference type="DOI" id="10.1074/jbc.m407448200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-727</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF SER-727</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="J. Virol." volume="78" first="5633" last="5641">
<title>Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively.</title>
<authorList>
<person name="Shaw M.L."/>
<person name="Garcia-Sastre A."/>
<person name="Palese P."/>
<person name="Basler C.F."/>
</authorList>
<dbReference type="PubMed" id="15140960"/>
<dbReference type="DOI" id="10.1128/jvi.78.11.5633-5641.2004"/>
</citation>
<scope>INTERACTION WITH NIPAH V AND W PROTEINS</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="336" first="496" last="506">
<title>Proteomic identification of proteins conjugated to ISG15 in mouse and human cells.</title>
<authorList>
<person name="Giannakopoulos N.V."/>
<person name="Luo J.K."/>
<person name="Papov V."/>
<person name="Zou W."/>
<person name="Lenschow D.J."/>
<person name="Jacobs B.S."/>
<person name="Borden E.C."/>
<person name="Li J."/>
<person name="Virgin H.W."/>
<person name="Zhang D.E."/>
</authorList>
<dbReference type="PubMed" id="16139798"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.08.132"/>
</citation>
<scope>ISGYLATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="Gastroenterology" volume="128" first="1034" last="1041">
<title>Hepatitis C virus expression suppresses interferon signaling by degrading STAT1.</title>
<authorList>
<person name="Lin W."/>
<person name="Choe W.H."/>
<person name="Hiasa Y."/>
<person name="Kamegaya Y."/>
<person name="Blackard J.T."/>
<person name="Schmidt E.V."/>
<person name="Chung R.T."/>
</authorList>
<dbReference type="PubMed" id="15825084"/>
<dbReference type="DOI" id="10.1053/j.gastro.2005.02.006"/>
</citation>
<scope>INTERACTION WITH HEPATITIS C VIRUS CORE PROTEIN</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="Bone" volume="41" first="273" last="281">
<title>Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLCgamma-activated STAT1.</title>
<authorList>
<person name="Harada D."/>
<person name="Yamanaka Y."/>
<person name="Ueda K."/>
<person name="Nishimura R."/>
<person name="Morishima T."/>
<person name="Seino Y."/>
<person name="Tanaka H."/>
</authorList>
<dbReference type="PubMed" id="17561467"/>
<dbReference type="DOI" id="10.1016/j.bone.2006.11.030"/>
</citation>
<scope>PHOSPHORYLATION IN RESPONSE TO ACTIVATED FGFR3</scope>
<scope>PHOSPHORYLATION AT TYR-701</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="J. Cell. Physiol." volume="212" first="148" last="156">
<title>Fibroblast growth factor receptor-induced phosphorylation of STAT1 at the Golgi apparatus without translocation to the nucleus.</title>
<authorList>
<person name="Citores L."/>
<person name="Bai L."/>
<person name="Sorensen V."/>
<person name="Olsnes S."/>
</authorList>
<dbReference type="PubMed" id="17311277"/>
<dbReference type="DOI" id="10.1002/jcp.21014"/>
</citation>
<scope>PHOSPHORYLATION IN RESPONSE TO ACTIVATED FGFR1; FGFR2; FGFR3 AND FGFR4</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2008" name="Biochem. J." volume="409" first="179" last="185">
<title>MAPK-induced Ser727 phosphorylation promotes SUMOylation of STAT1.</title>
<authorList>
<person name="Vanhatupa S."/>
<person name="Ungureanu D."/>
<person name="Paakkunainen M."/>
<person name="Silvennoinen O."/>
</authorList>
<dbReference type="PubMed" id="17897103"/>
<dbReference type="DOI" id="10.1042/bj20070620"/>
</citation>
<scope>PHOSPHORYLATION AT SER-727</scope>
<scope>INTERACTION WITH PIAS1</scope>
<scope>SUMOYLATION</scope>
<scope>MUTAGENESIS OF TYR-701 AND SER-727</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2008" name="Chem. Biol." volume="15" first="808" last="817">
<title>System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties.</title>
<authorList>
<person name="Kaushansky A."/>
<person name="Gordus A."/>
<person name="Budnik B.A."/>
<person name="Lane W.S."/>
<person name="Rush J."/>
<person name="MacBeath G."/>
</authorList>
<dbReference type="PubMed" id="18721752"/>
<dbReference type="DOI" id="10.1016/j.chembiol.2008.07.006"/>
</citation>
<scope>INTERACTION WITH ERBB4</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-727</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2008" name="PLoS ONE" volume="3" first="E3961" last="E3961">
<title>Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage.</title>
<authorList>
<person name="Krejci P."/>
<person name="Salazar L."/>
<person name="Kashiwada T.A."/>
<person name="Chlebova K."/>
<person name="Salasova A."/>
<person name="Thompson L.M."/>
<person name="Bryja V."/>
<person name="Kozubik A."/>
<person name="Wilcox W.R."/>
</authorList>
<dbReference type="PubMed" id="19088846"/>
<dbReference type="DOI" id="10.1371/journal.pone.0003961"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT TYR-701 IN RESPONSE TO CONSTITUTIVELY ACTIVATED FGFR3</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-727</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="Genes Dev." volume="23" first="118" last="132">
<title>PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling.</title>
<authorList>
<person name="Weber S."/>
<person name="Maass F."/>
<person name="Schuemann M."/>
<person name="Krause E."/>
<person name="Suske G."/>
<person name="Bauer U.M."/>
</authorList>
<dbReference type="PubMed" id="19136629"/>
<dbReference type="DOI" id="10.1101/gad.489409"/>
</citation>
<scope>RETRACTED PAPER</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="Genes Dev." volume="25" first="1451" last="1451">
<title>Retraction. PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling.</title>
<authorList>
<person name="Weber S."/>
<person name="Maass F."/>
<person name="Schuemann M."/>
<person name="Krause E."/>
<person name="Suske G."/>
<person name="Bauer U.M."/>
</authorList>
<dbReference type="PubMed" id="21724836"/>
</citation>
<scope>RETRACTION NOTICE OF PUBMED:19136629</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-727</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-727</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="5956" last="5966">
<title>Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells.</title>
<authorList>
<person name="Chaix A."/>
<person name="Lopez S."/>
<person name="Voisset E."/>
<person name="Gros L."/>
<person name="Dubreuil P."/>
<person name="De Sepulveda P."/>
</authorList>
<dbReference type="PubMed" id="21135090"/>
<dbReference type="DOI" id="10.1074/jbc.m110.182642"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-701 IN RESPONSE TO KIT SIGNALING</scope>
<scope>PHOSPHORYLATION AT SER-727</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="44412" last="44423">
<title>Inhibitor of kappaB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection.</title>
<authorList>
<person name="Perwitasari O."/>
<person name="Cho H."/>
<person name="Diamond M.S."/>
<person name="Gale M. Jr."/>
</authorList>
<dbReference type="PubMed" id="22065572"/>
<dbReference type="DOI" id="10.1074/jbc.m111.285205"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-701; SER-708 AND SER-727</scope>
<scope>MUTAGENESIS OF TYR-701; SER-708 AND SER-727</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2012" name="PLoS Pathog." volume="8" first="E1002550" last="E1002550">
<title>The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold.</title>
<authorList>
<person name="Zhang A.P."/>
<person name="Bornholdt Z.A."/>
<person name="Liu T."/>
<person name="Abelson D.M."/>
<person name="Lee D.E."/>
<person name="Li S."/>
<person name="Woods V.L. Jr."/>
<person name="Saphire E.O."/>
</authorList>
<dbReference type="PubMed" id="22383882"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1002550"/>
</citation>
<scope>INTERACTION WITH EBOLAVIRUS PROTEIN VP24 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-727</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="46">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="47">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-703</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2015" name="Nat. Immunol." volume="16" first="1215" last="1227">
<title>PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Mao D."/>
<person name="Roswit W.T."/>
<person name="Jin X."/>
<person name="Patel A.C."/>
<person name="Patel D.A."/>
<person name="Agapov E."/>
<person name="Wang Z."/>
<person name="Tidwell R.M."/>
<person name="Atkinson J.J."/>
<person name="Huang G."/>
<person name="McCarthy R."/>
<person name="Yu J."/>
<person name="Yun N.E."/>
<person name="Paessler S."/>
<person name="Lawson T.G."/>
<person name="Omattage N.S."/>
<person name="Brett T.J."/>
<person name="Holtzman M.J."/>
</authorList>
<dbReference type="PubMed" id="26479788"/>
<dbReference type="DOI" id="10.1038/ni.3279"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PARP9; DTX3L AND EP300</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH PARP9 AND DTX3L</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT TYR-701 AND SER-727</scope>
<scope>MUTAGENESIS OF 656-ALA--ASN-658 AND TYR-701</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2016" name="Nat. Commun." volume="7" first="12849" last="12849">
<title>PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation.</title>
<authorList>
<person name="Iwata H."/>
<person name="Goettsch C."/>
<person name="Sharma A."/>
<person name="Ricchiuto P."/>
<person name="Goh W.W."/>
<person name="Halu A."/>
<person name="Yamada I."/>
<person name="Yoshida H."/>
<person name="Hara T."/>
<person name="Wei M."/>
<person name="Inoue N."/>
<person name="Fukuda D."/>
<person name="Mojcher A."/>
<person name="Mattson P.C."/>
<person name="Barabasi A.L."/>
<person name="Boothby M."/>
<person name="Aikawa E."/>
<person name="Singh S.A."/>
<person name="Aikawa M."/>
</authorList>
<dbReference type="PubMed" id="27796300"/>
<dbReference type="DOI" id="10.1038/ncomms12849"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT TYR-701</scope>
<scope>ADP-RIBOSYLATION AT GLU-657 AND GLU-705</scope>
<scope>MUTAGENESIS OF GLU-657 AND GLU-705</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2017" name="Cell" volume="170" first="492" last="506">
<title>Methyltransferase SETD2-mediated methylation of STAT1 is critical for interferon antiviral activity.</title>
<authorList>
<person name="Chen K."/>
<person name="Liu J."/>
<person name="Liu S."/>
<person name="Xia M."/>
<person name="Zhang X."/>
<person name="Han D."/>
<person name="Jiang Y."/>
<person name="Wang C."/>
<person name="Cao X."/>
</authorList>
<dbReference type="PubMed" id="28753426"/>
<dbReference type="DOI" id="10.1016/j.cell.2017.06.042"/>
</citation>
<scope>METHYLATION AT LYS-114; LYS-175; LYS-296; LYS-366; LYS-525; LYS-637 AND LYS-665</scope>
<scope>PHOSPHORYLATION AT TYR-701</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF LYS-114; LYS-175; LYS-296; LYS-366; LYS-525; 636-LYS-LYS-637 AND LYS-665</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-703</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2018" name="Nat. Commun." volume="9" first="2144" last="2144">
<title>On the role of STAT1 and STAT6 ADP-ribosylation in the regulation of macrophage activation.</title>
<authorList>
<person name="Begitt A."/>
<person name="Cavey J."/>
<person name="Droescher M."/>
<person name="Vinkemeier U."/>
</authorList>
<dbReference type="PubMed" id="29858569"/>
<dbReference type="DOI" id="10.1038/s41467-018-04522-z"/>
</citation>
<scope>COMMENT ON ADP-RIBOSYLATION</scope>
</reference>
<reference key="53">
<citation type="journal article" date="1998" name="Cell" volume="93" first="827" last="839">
<title>Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA.</title>
<authorList>
<person name="Chen X."/>
<person name="Vinkemeier U."/>
<person name="Zhao Y."/>
<person name="Jeruzalmi D."/>
<person name="Darnell J.E. Jr."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="9630226"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)81443-9"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 136-710</scope>
<scope>COILED-COIL</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2001" name="Science" volume="293" first="300" last="303">
<title>Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation.</title>
<authorList>
<person name="Dupuis S."/>
<person name="Dargemont C."/>
<person name="Fieschi C."/>
<person name="Thomassin N."/>
<person name="Rosenzweig S."/>
<person name="Harris J."/>
<person name="Holland S.M."/>
<person name="Schreiber R.D."/>
<person name="Casanova J.-L."/>
</authorList>
<dbReference type="PubMed" id="11452125"/>
<dbReference type="DOI" id="10.1126/science.1061154"/>
</citation>
<scope>VARIANT IMD31A SER-706</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2003" name="Nat. Genet." volume="33" first="388" last="391">
<title>Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency.</title>
<authorList>
<person name="Dupuis S."/>
<person name="Jouanguy E."/>
<person name="Al-Hajjar S."/>
<person name="Fieschi C."/>
<person name="Al-Mohsen I.Z."/>
<person name="Al-Jumaah S."/>
<person name="Yang K."/>
<person name="Chapgier A."/>
<person name="Eidenschenk C."/>
<person name="Eid P."/>
<person name="Al-Ghonaium A."/>
<person name="Tufenkeji H."/>
<person name="Frayha H."/>
<person name="Al-Gazlan S."/>
<person name="Al-Rayes H."/>
<person name="Schreiber R.D."/>
<person name="Gresser I."/>
<person name="Casanova J.L."/>
</authorList>
<dbReference type="PubMed" id="12590259"/>
<dbReference type="DOI" id="10.1038/ng1097"/>
</citation>
<scope>VARIANT IMD31B PRO-600</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2006" name="PLoS Genet." volume="2" first="E131" last="E131">
<title>Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease.</title>
<authorList>
<person name="Chapgier A."/>
<person name="Boisson-Dupuis S."/>
<person name="Jouanguy E."/>
<person name="Vogt G."/>
<person name="Feinberg J."/>
<person name="Prochnicka-Chalufour A."/>
<person name="Casrouge A."/>
<person name="Yang K."/>
<person name="Soudais C."/>
<person name="Fieschi C."/>
<person name="Santos O.F."/>
<person name="Bustamante J."/>
<person name="Picard C."/>
<person name="de Beaucoudrey L."/>
<person name="Emile J.F."/>
<person name="Arkwright P.D."/>
<person name="Schreiber R.D."/>
<person name="Rolinck-Werninghaus C."/>
<person name="Rosen-Wolff A."/>
<person name="Magdorf K."/>
<person name="Roesler J."/>
<person name="Casanova J.L."/>
</authorList>
<dbReference type="PubMed" id="16934001"/>
<dbReference type="DOI" id="10.1371/journal.pgen.0020131"/>
</citation>
<scope>VARIANTS IMD31A GLN-320 AND HIS-463</scope>
<scope>CHARACTERIZATION OF VARIANTS GLN-320; HIS-463 AND SER-706</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] ALA-491</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2010" name="Blood" volume="116" first="5895" last="5906">
<title>A novel form of human STAT1 deficiency impairing early but not late responses to interferons.</title>
<authorList>
<person name="Kong X.F."/>
<person name="Ciancanelli M."/>
<person name="Al-Hajjar S."/>
<person name="Alsina L."/>
<person name="Zumwalt T."/>
<person name="Bustamante J."/>
<person name="Feinberg J."/>
<person name="Audry M."/>
<person name="Prando C."/>
<person name="Bryant V."/>
<person name="Kreins A."/>
<person name="Bogunovic D."/>
<person name="Halwani R."/>
<person name="Zhang X.X."/>
<person name="Abel L."/>
<person name="Chaussabel D."/>
<person name="Al-Muhsen S."/>
<person name="Casanova J.L."/>
<person name="Boisson-Dupuis S."/>
</authorList>
<dbReference type="PubMed" id="20841510"/>
<dbReference type="DOI" id="10.1182/blood-2010-04-280586"/>
</citation>
<scope>VARIANT IMD31B ASN-201</scope>
<scope>CHARACTERIZATION OF VARIANT IMD31B ASN-201</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2011" name="J. Exp. Med." volume="208" first="1635" last="1648">
<title>Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.</title>
<authorList>
<person name="Liu L."/>
<person name="Okada S."/>
<person name="Kong X.F."/>
<person name="Kreins A.Y."/>
<person name="Cypowyj S."/>
<person name="Abhyankar A."/>
<person name="Toubiana J."/>
<person name="Itan Y."/>
<person name="Audry M."/>
<person name="Nitschke P."/>
<person name="Masson C."/>
<person name="Toth B."/>
<person name="Flatot J."/>
<person name="Migaud M."/>
<person name="Chrabieh M."/>
<person name="Kochetkov T."/>
<person name="Bolze A."/>
<person name="Borghesi A."/>
<person name="Toulon A."/>
<person name="Hiller J."/>
<person name="Eyerich S."/>
<person name="Eyerich K."/>
<person name="Gulacsy V."/>
<person name="Chernyshova L."/>
<person name="Chernyshov V."/>
<person name="Bondarenko A."/>
<person name="Maria Cortes Grimaldo R."/>
<person name="Blancas-Galicia L."/>
<person name="Madrigal Beas I.M."/>
<person name="Roesler J."/>
<person name="Magdorf K."/>
<person name="Engelhard D."/>
<person name="Thumerelle C."/>
<person name="Burgel P.R."/>
<person name="Hoernes M."/>
<person name="Drexel B."/>
<person name="Seger R."/>
<person name="Kusuma T."/>
<person name="Jansson A.F."/>
<person name="Sawalle-Belohradsky J."/>
<person name="Belohradsky B."/>
<person name="Jouanguy E."/>
<person name="Bustamante J."/>
<person name="Bue M."/>
<person name="Karin N."/>
<person name="Wildbaum G."/>
<person name="Bodemer C."/>
<person name="Lortholary O."/>
<person name="Fischer A."/>
<person name="Blanche S."/>
<person name="Al-Muhsen S."/>
<person name="Reichenbach J."/>
<person name="Kobayashi M."/>
<person name="Rosales F.E."/>
<person name="Lozano C.T."/>
<person name="Kilic S.S."/>
<person name="Oleastro M."/>
<person name="Etzioni A."/>
<person name="Traidl-Hoffmann C."/>
<person name="Renner E.D."/>
<person name="Abel L."/>
<person name="Picard C."/>
<person name="Marodi L."/>
<person name="Boisson-Dupuis S."/>
<person name="Puel A."/>
<person name="Casanova J.L."/>
</authorList>
<dbReference type="PubMed" id="21727188"/>
<dbReference type="DOI" id="10.1084/jem.20110958"/>
</citation>
<scope>VARIANTS IMD31C GLY-165; HIS-165; ASN-170; ARG-174; ILE-202; VAL-202; VAL-267; PRO-271; GLN-274; TRP-274; ILE-286 AND ALA-288</scope>
<scope>CHARACTERIZATION OF VARIANTS IMD31C GLY-165 AND GLN-274</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2011" name="N. Engl. J. Med." volume="365" first="54" last="61">
<title>STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis.</title>
<authorList>
<person name="van de Veerdonk F.L."/>
<person name="Plantinga T.S."/>
<person name="Hoischen A."/>
<person name="Smeekens S.P."/>
<person name="Joosten L.A."/>
<person name="Gilissen C."/>
<person name="Arts P."/>
<person name="Rosentul D.C."/>
<person name="Carmichael A.J."/>
<person name="Smits-van der Graaf C.A."/>
<person name="Kullberg B.J."/>
<person name="van der Meer J.W."/>
<person name="Lilic D."/>
<person name="Veltman J.A."/>
<person name="Netea M.G."/>
</authorList>
<dbReference type="PubMed" id="21714643"/>
<dbReference type="DOI" id="10.1056/nejmoa1100102"/>
</citation>
<scope>VARIANTS IMD31C VAL-267 AND TRP-274</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2012" name="Hum. Mutat." volume="33" first="1377" last="1387">
<title>Dominant-negative STAT1 SH2 domain mutations in unrelated patients with Mendelian susceptibility to mycobacterial disease.</title>
<authorList>
<person name="Tsumura M."/>
<person name="Okada S."/>
<person name="Sakai H."/>
<person name="Yasunaga S."/>
<person name="Ohtsubo M."/>
<person name="Murata T."/>
<person name="Obata H."/>
<person name="Yasumi T."/>
<person name="Kong X.F."/>
<person name="Abhyankar A."/>
<person name="Heike T."/>
<person name="Nakahata T."/>
<person name="Nishikomori R."/>
<person name="Al-Muhsen S."/>
<person name="Boisson-Dupuis S."/>
<person name="Casanova J.L."/>
<person name="Alzahrani M."/>
<person name="Shehri M.A."/>
<person name="Elghazali G."/>
<person name="Takihara Y."/>
<person name="Kobayashi M."/>
</authorList>
<dbReference type="PubMed" id="22573496"/>
<dbReference type="DOI" id="10.1002/humu.22113"/>
</citation>
<scope>VARIANTS IMD31A GLU-637 AND ARG-673</scope>
<scope>CHARACTERIZATION OF VARIANTS IMD31A GLU-637 AND ARG-673</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2013" name="J. Med. Genet." volume="50" first="567" last="578">
<title>New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe.</title>
<authorList>
<person name="Soltesz B."/>
<person name="Toth B."/>
<person name="Shabashova N."/>
<person name="Bondarenko A."/>
<person name="Okada S."/>
<person name="Cypowyj S."/>
<person name="Abhyankar A."/>
<person name="Csorba G."/>
<person name="Tasko S."/>
<person name="Sarkadi A.K."/>
<person name="Mehes L."/>
<person name="Rozsival P."/>
<person name="Neumann D."/>
<person name="Chernyshova L."/>
<person name="Tulassay Z."/>
<person name="Puel A."/>
<person name="Casanova J.L."/>
<person name="Sediva A."/>
<person name="Litzman J."/>
<person name="Marodi L."/>
</authorList>
<dbReference type="PubMed" id="23709754"/>
<dbReference type="DOI" id="10.1136/jmedgenet-2013-101570"/>
</citation>
<scope>VARIANTS IMD31C GLY-165; LYS-179; GLN-274; TRP-274; ARG-285 AND MET-385</scope>
<scope>CHARACTERIZATION OF VARIANTS IMD31C LYS-179; GLN-274; TRP-274; ARG-285 AND MET-385</scope>
<scope>CHARACTERIZATION OF VARIANT IMD31B CYS-701</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2014" name="J. Immunol." volume="193" first="4880" last="4887">
<title>Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody.</title>
<authorList>
<person name="Yamazaki Y."/>
<person name="Yamada M."/>
<person name="Kawai T."/>
<person name="Morio T."/>
<person name="Onodera M."/>
<person name="Ueki M."/>
<person name="Watanabe N."/>
<person name="Takada H."/>
<person name="Takezaki S."/>
<person name="Chida N."/>
<person name="Kobayashi I."/>
<person name="Ariga T."/>
</authorList>
<dbReference type="PubMed" id="25288569"/>
<dbReference type="DOI" id="10.4049/jimmunol.1401467"/>
</citation>
<scope>VARIANTS IMD31C GLU-278 AND ASP-384</scope>
<scope>CHARACTERIZATION OF VARIANTS IMD31C GLU-278; ASP-384 AND MET-385</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2015" name="Mol. Immunol." volume="68" first="597" last="605">
<title>A novel gain-of-function STAT1 mutation resulting in basal phosphorylation of STAT1 and increased distal IFN-gamma-mediated responses in chronic mucocutaneous candidiasis.</title>
<authorList>
<person name="Martinez-Martinez L."/>
<person name="Martinez-Saavedra M.T."/>
<person name="Fuentes-Prior P."/>
<person name="Barnadas M."/>
<person name="Rubiales M.V."/>
<person name="Noda J."/>
<person name="Badell I."/>
<person name="Rodriguez-Gallego C."/>
<person name="Calle-Martin O.L."/>
</authorList>
<dbReference type="PubMed" id="26514428"/>
<dbReference type="DOI" id="10.1016/j.molimm.2015.09.014"/>
</citation>
<scope>VARIANT IMD31C ASN-298</scope>
<scope>CHARACTERIZATION OF VARIANT IMD31C ASN-298</scope>
</reference>
<comment type="function">
<text evidence="19 20 22 30 40 43 49">Signal transducer and transcription activator that mediates cellular responses to interferons (IFNs), cytokine KITLG/SCF and other cytokines and other growth factors. Following type I IFN (IFN-alpha and IFN-beta) binding to cell surface receptors, signaling via protein kinases leads to activation of Jak kinases (TYK2 and JAK1) and to tyrosine phosphorylation of STAT1 and STAT2. The phosphorylated STATs dimerize and associate with ISGF3G/IRF-9 to form a complex termed ISGF3 transcription factor, that enters the nucleus (PubMed:28753426). ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of IFN-stimulated genes (ISG), which drive the cell in an antiviral state. In response to type II IFN (IFN-gamma), STAT1 is tyrosine- and serine-phosphorylated (PubMed:26479788). It then forms a homodimer termed IFN-gamma-activated factor (GAF), migrates into the nucleus and binds to the IFN gamma activated sequence (GAS) to drive the expression of the target genes, inducing a cellular antiviral state. Becomes activated in response to KITLG/SCF and KIT signaling. May mediate cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4.</text>
</comment>
<comment type="subunit">
<text evidence="13 15 28 29 40 43 46 47 49 50">Isoform alpha homodimerizes upon IFN-gamma induced phosphorylation (PubMed:8605877, PubMed:28753426). Heterodimer with STAT2 upon IFN-alpha/beta induced phosphorylation (PubMed:8605877). The heterodimer STAT1:STAT2 forms the interferon-stimulated gene factor 3 complex (ISGF3) with IRF9 (By similarity). Interacts (phosphorylated at Ser-727) with PIAS1; the interaction results in release of STAT1 from its target gene (PubMed:9724754, PubMed:17897103). Interacts with IFNAR1; the interaction requires the phosphorylation of IFNAR1 at 'Tyr-466' (PubMed:9121453). Interacts with IFNAR2 (PubMed:9121453). Found in a complex with NMI and CREBBP/CBP (PubMed:9989503). Interacts with NMI which is required for CREBBP/CBP recruitment to the complex (PubMed:9989503). Interacts with PTK2/FAK1 (PubMed:11278462). Interacts with SRC (By similarity). Interacts with ERBB4 (phosphorylated) (PubMed:18721752). Interacts with PARP9 and DTX3L independently of IFN-beta or IFN-gamma-mediated STAT1 'Tyr-701' phosphorylation (PubMed:26479788). Interacts with histone acetyltransferase EP300/p300 in response to INF-gamma stimulation (PubMed:26479788). Interacts with OTOP1 (By similarity).</text>
</comment>
<comment type="subunit">
<text>(Microbial infection) Interacts with Sendai virus C', C, Y1 and Y2 proteins, preventing activation of ISRE and GAS promoter.</text>
</comment>
<comment type="subunit">
<text>(Microbial infection) Interacts with Nipah virus P, V and W proteins preventing activation of ISRE and GAS promoter.</text>
</comment>
<comment type="subunit">
<text evidence="16 21">(Microbial infection) Interacts with Rabies virus phosphoprotein preventing activation of ISRE and GAS promoter.</text>
</comment>
<comment type="subunit">
<text evidence="23">(Microbial infection) Interacts with HCV core protein; the interaction results in STAT1 degradation.</text>
</comment>
<comment type="subunit">
<text evidence="36">(Microbial infection) Interacts with ebolavirus protein VP24.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-350322">
<id>Q16531</id>
<label>DDB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-995350">
<id>O95786</id>
<label>DDX58</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-448924">
<id>Q01094</id>
<label>E2F1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-750700">
<id>Q8N9N8</id>
<label>EIF1AD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-852851">
<id>P01100</id>
<label>FOS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-1547250">
<id>P17181</id>
<label>IFNAR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-958408">
<id>P48551</id>
<label>IFNAR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-1030755">
<id>P15260</id>
<label>IFNGR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-358383">
<id>P52294</id>
<label>KPNA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
<label>MAVS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-1054396">
<id>Q01804</id>
<label>OTUD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-78598">
<id>P19793</id>
<label>RXRA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-1057697">
<id>P42224</id>
<label>STAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-1546963">
<id>P52630</id>
<label>STAT2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-518675">
<id>P40763</id>
<label>STAT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-7789600">
<id>P07239</id>
<label>H1L</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-11499224">
<id>Q4VW77</id>
<label>UL47</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-6692439">
<id>P03255-1</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-6859460">
<id>P03255-2</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-6941357">
<id>P26664</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-6377335">
<id>PRO_0000037566</id>
<dbReference type="UniProtKB" id="P27958"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1057697">
<id>P42224</id>
</interactant>
<interactant intactId="EBI-8753518">
<id>PRO_0000037576</id>
<dbReference type="UniProtKB" id="P27958"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15711971">
<id>P42224-1</id>
</interactant>
<interactant intactId="EBI-2515339">
<id>Q9Y4C1</id>
<label>KDM3A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15711971">
<id>P42224-1</id>
</interactant>
<interactant intactId="EBI-15711971">
<id>P42224-1</id>
<label>STAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15711971">
<id>P42224-1</id>
</interactant>
<interactant intactId="EBI-16085959">
<id>P06498</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15712015">
<id>P42224-2</id>
</interactant>
<interactant intactId="EBI-15712015">
<id>P42224-2</id>
<label>STAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="22 40 42 43">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="22 40 43">Nucleus</location>
</subcellularLocation>
<text evidence="22 40 43">Translocated into the nucleus upon tyrosine phosphorylation and dimerization, in response to IFN-gamma and signaling by activated FGFR1, FGFR2, FGFR3 or FGFR4 (PubMed:15322115). Monomethylation at Lys-525 is required for phosphorylation at Tyr-701 and translocation into the nucleus (PubMed:28753426). Translocates into the nucleus in response to interferon-beta stimulation (PubMed:26479788).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P42224-1</id>
<name>Alpha</name>
<name>p91</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P42224-2</id>
<name>Beta</name>
<name>p84</name>
<sequence type="described" ref="VSP_006282"/>
</isoform>
</comment>
<comment type="PTM">
<text evidence="22 27 28 30 32 35 40 43 44 45">Phosphorylated on tyrosine and serine residues in response to a variety of cytokines/growth hormones including IFN-alpha, IFN-gamma, PDGF and EGF. Activated KIT promotes phosphorylation on tyrosine residues and subsequent translocation to the nucleus. Upon EGF stimulation, phosphorylation on Tyr-701 (lacking in beta form) by JAK1, JAK2 or TYK2 promotes dimerization and subsequent translocation to the nucleus. Growth hormone (GH) activates STAT1 signaling only via JAK2. Tyrosine phosphorylated in response to constitutively activated FGFR1, FGFR2, FGFR3 and FGFR4. Phosphorylation on Ser-727 by several kinases including MAPK14, ERK1/2 and CAMKII on IFN-gamma stimulation, regulates STAT1 transcriptional activity. Phosphorylation on Ser-727 promotes sumoylation though increasing interaction with PIAS. Phosphorylation on Ser-727 by PRKCD induces apoptosis in response to DNA-damaging agents. Phosphorylated on tyrosine residues when PTK2/FAK1 is activated; most likely this is catalyzed by a SRC family kinase. Dephosphorylation on tyrosine residues by PTPN2 negatively regulates interferon-mediated signaling. Upon viral infection or IFN induction, phosphorylation on Ser-708 occurs much later than phosphorylation on Tyr-701 and is required for the binding of ISGF3 on the ISREs of a subset of IFN-stimulated genes IKBKE-dependent. Phosphorylation at Tyr-701 and Ser-708 are mutually exclusive, phosphorylation at Ser-708 requires previous dephosphorylation of Tyr-701.</text>
</comment>
<comment type="PTM">
<text evidence="22 28 32 35 44">Sumoylated with SUMO1, SUMO2 and SUMO3. Sumoylation is enhanced by IFN-gamma-induced phosphorylation on Ser-727, and by interaction with PIAS proteins. Enhances the transactivation activity.</text>
</comment>
<comment type="PTM">
<text evidence="24">ISGylated.</text>
</comment>
<comment type="PTM">
<text evidence="42 54">Mono-ADP-ribosylated at Glu-657 and Glu-705 by PARP14; ADP-ribosylation prevents phosphorylation at Tyr-701 (PubMed:27796300). However, the role of ADP-ribosylation in the prevention of phosphorylation has been called into question and the lack of phosphorylation may be due to sumoylation of Lys-703 (PubMed:29858569).</text>
</comment>
<comment type="PTM">
<text evidence="43">Monomethylated at Lys-525 by SETD2; monomethylation is necessary for phosphorylation at Tyr-701, translocation into the nucleus and activation of the antiviral defense.</text>
</comment>
<comment type="disease" evidence="18 31 38">
<disease id="DI-03106">
<name>Immunodeficiency 31B</name>
<acronym>IMD31B</acronym>
<description>A disorder characterized by susceptibility to severe mycobacterial and viral infections. Affected individuals can develop disseminated infections and die of viral illness.</description>
<dbReference type="MIM" id="613796"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="17 25 37">
<disease id="DI-04224">
<name>Immunodeficiency 31A</name>
<acronym>IMD31A</acronym>
<description>A form of Mendelian susceptibility to mycobacterial disease, a rare condition caused by impairment of interferon-gamma mediated immunity. It is characterized by predisposition to illness caused by moderately virulent mycobacterial species, such as Bacillus Calmette-Guerin (BCG) vaccine, environmental non-tuberculous mycobacteria, and by the more virulent Mycobacterium tuberculosis. Other microorganisms rarely cause severe clinical disease in individuals with susceptibility to mycobacterial infections, with the exception of Salmonella which infects less than 50% of these individuals. Clinical outcome severity depends on the degree of impairment of interferon-gamma mediated immunity. Some patients die of overwhelming mycobacterial disease with lepromatous-like lesions in early childhood, whereas others develop, later in life, disseminated but curable infections with tuberculoid granulomas. IMD31A has low penetrance, and affected individuals have relatively mild disease and good prognosis. IMD31A confers a predisposition to mycobacterial infections only, with no increased susceptibility to viral infections.</description>
<dbReference type="MIM" id="614892"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="33 34 38 39 41">
<disease id="DI-03179">
<name>Immunodeficiency 31C</name>
<acronym>IMD31C</acronym>
<description>A primary immunodeficiency disorder with altered immune responses and impaired clearance of fungal infections, selective against Candida. It is characterized by persistent and/or recurrent infections of the skin, nails and mucous membranes caused by organisms of the genus Candida, mainly Candida albicans.</description>
<dbReference type="MIM" id="614162"/>
</disease>
<text evidence="33">The disease is caused by mutations affecting the gene represented in this entry. STAT1 mutations in patients with autosomal dominant candidiasis lead to defective responses of type 1 and type 17 helper T-cells, characterized by reduced production of interferon-alpha, interleukin-17, and interleukin-22. These cytokines are crucial for the antifungal defense of skin and mucosa (PubMed:21714643).</text>
</comment>
<comment type="similarity">
<text evidence="53">Belongs to the transcription factor STAT family.</text>
</comment>
<comment type="caution">
<text evidence="42 54">Has been shown to be mono-ADP-ribosylated at Glu-657 and Glu-705 by PARP14 which prevents phosphorylation at Tyr-701 (PubMed:27796300). However, the role of ADP-ribosylation in the prevention of phosphorylation has been called into question (PubMed:29858569). It has been suggested that the lack of phosphorylation may be due to sumoylation of Lys-703 (PubMed:29858569).</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/stat1/"/>
</comment>
<comment type="online information" name="STAT1base">
<link uri="http://structure.bmc.lu.se/idbase/STAT1base/"/>
<text>STAT1 mutation db</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/STAT1"/>
<text>STAT1 entry</text>
</comment>
<dbReference type="EMBL" id="M97935">
<property type="protein sequence ID" value="AAB64012.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M97936">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="GU211347">
<property type="protein sequence ID" value="ADA59516.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY865620">
<property type="protein sequence ID" value="AAW56072.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292604">
<property type="protein sequence ID" value="BAF85293.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK315002">
<property type="protein sequence ID" value="BAG37497.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR749636">
<property type="protein sequence ID" value="CAH18430.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT007241">
<property type="protein sequence ID" value="AAP35905.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC067945">
<property type="protein sequence ID" value="AAY24183.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471058">
<property type="protein sequence ID" value="EAX10850.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471058">
<property type="protein sequence ID" value="EAX10851.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471058">
<property type="protein sequence ID" value="EAX10852.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471058">
<property type="protein sequence ID" value="EAX10855.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC002704">
<property type="protein sequence ID" value="AAH02704.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U18662">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U18663">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U18664">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U18665">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U18666">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U18667">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U18668">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U18669">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U18670">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2309.1">
<molecule id="P42224-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS42793.1">
<molecule id="P42224-2"/>
</dbReference>
<dbReference type="PIR" id="A46159">
<property type="entry name" value="A46159"/>
</dbReference>
<dbReference type="RefSeq" id="NP_009330.1">
<molecule id="P42224-1"/>
<property type="nucleotide sequence ID" value="NM_007315.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_644671.1">
<molecule id="P42224-2"/>
<property type="nucleotide sequence ID" value="NM_139266.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006712781.1">
<molecule id="P42224-1"/>
<property type="nucleotide sequence ID" value="XM_006712718.1"/>
</dbReference>
<dbReference type="PDB" id="1BF5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=136-710"/>
</dbReference>
<dbReference type="PDB" id="1YVL">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=1-683"/>
</dbReference>
<dbReference type="PDB" id="2KA6">
<property type="method" value="NMR"/>
<property type="chains" value="B=710-750"/>
</dbReference>
<dbReference type="PDB" id="3WWT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1-126"/>
</dbReference>
<dbReference type="PDBsum" id="1BF5"/>
<dbReference type="PDBsum" id="1YVL"/>
<dbReference type="PDBsum" id="2KA6"/>
<dbReference type="PDBsum" id="3WWT"/>
<dbReference type="SMR" id="P42224"/>
<dbReference type="BioGRID" id="112649">
<property type="interactions" value="193"/>
</dbReference>
<dbReference type="CORUM" id="P42224"/>
<dbReference type="DIP" id="DIP-46140N"/>
<dbReference type="IntAct" id="P42224">
<property type="interactions" value="162"/>
</dbReference>
<dbReference type="MINT" id="P42224"/>
<dbReference type="STRING" id="9606.ENSP00000354394"/>
<dbReference type="BindingDB" id="P42224"/>
<dbReference type="ChEMBL" id="CHEMBL6101"/>
<dbReference type="CarbonylDB" id="P42224"/>
<dbReference type="iPTMnet" id="P42224"/>
<dbReference type="MetOSite" id="P42224"/>
<dbReference type="PhosphoSitePlus" id="P42224"/>
<dbReference type="SwissPalm" id="P42224"/>
<dbReference type="BioMuta" id="STAT1"/>
<dbReference type="DMDM" id="2507413"/>
<dbReference type="CPTAC" id="CPTAC-1272"/>
<dbReference type="CPTAC" id="CPTAC-1746"/>
<dbReference type="EPD" id="P42224"/>
<dbReference type="jPOST" id="P42224"/>
<dbReference type="MassIVE" id="P42224"/>
<dbReference type="MaxQB" id="P42224"/>
<dbReference type="PaxDb" id="P42224"/>
<dbReference type="PeptideAtlas" id="P42224"/>
<dbReference type="PRIDE" id="P42224"/>
<dbReference type="ProteomicsDB" id="55491">
<molecule id="P42224-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55492">
<molecule id="P42224-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="688">
<property type="antibodies" value="2281 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="6772"/>
<dbReference type="Ensembl" id="ENST00000361099">
<molecule id="P42224-1"/>
<property type="protein sequence ID" value="ENSP00000354394"/>
<property type="gene ID" value="ENSG00000115415"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000392322">
<molecule id="P42224-2"/>
<property type="protein sequence ID" value="ENSP00000376136"/>
<property type="gene ID" value="ENSG00000115415"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000409465">
<molecule id="P42224-1"/>
<property type="protein sequence ID" value="ENSP00000386244"/>
<property type="gene ID" value="ENSG00000115415"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000415035">
<molecule id="P42224-1"/>
<property type="protein sequence ID" value="ENSP00000388240"/>
<property type="gene ID" value="ENSG00000115415"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000540176">
<molecule id="P42224-1"/>
<property type="protein sequence ID" value="ENSP00000438703"/>
<property type="gene ID" value="ENSG00000115415"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000673841">
<molecule id="P42224-2"/>
<property type="protein sequence ID" value="ENSP00000501225"/>
<property type="gene ID" value="ENSG00000115415"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000674080">
<molecule id="P42224-2"/>
<property type="protein sequence ID" value="ENSP00000501164"/>
<property type="gene ID" value="ENSG00000115415"/>
</dbReference>
<dbReference type="GeneID" id="6772"/>
<dbReference type="KEGG" id="hsa:6772"/>
<dbReference type="UCSC" id="uc002usj.3">
<molecule id="P42224-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6772"/>
<dbReference type="DisGeNET" id="6772"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000115415.18"/>
<dbReference type="GeneCards" id="STAT1"/>
<dbReference type="HGNC" id="HGNC:11362">
<property type="gene designation" value="STAT1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000115415">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="STAT1"/>
<dbReference type="MIM" id="600555">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="613796">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="614162">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="614892">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P42224"/>
<dbReference type="OpenTargets" id="ENSG00000115415"/>
<dbReference type="Orphanet" id="391487">
<property type="disease" value="Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="319595">
<property type="disease" value="Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency"/>
</dbReference>
<dbReference type="Orphanet" id="391311">
<property type="disease" value="Susceptibility to viral and mycobacterial infections due to STAT1 deficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36183"/>
<dbReference type="eggNOG" id="KOG3667">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00990000203599"/>
<dbReference type="HOGENOM" id="CLU_014189_3_0_1"/>
<dbReference type="InParanoid" id="P42224"/>
<dbReference type="KO" id="K11220"/>
<dbReference type="OMA" id="DTMMNAV"/>
<dbReference type="OrthoDB" id="327469at2759"/>
<dbReference type="PhylomeDB" id="P42224"/>
<dbReference type="TreeFam" id="TF318648"/>
<dbReference type="PathwayCommons" id="P42224"/>
<dbReference type="Reactome" id="R-HSA-1059683">
<molecule id="P42224-1"/>
<property type="pathway name" value="Interleukin-6 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1169408">
<property type="pathway name" value="ISG15 antiviral mechanism"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1433557">
<molecule id="P42224-1"/>
<property type="pathway name" value="Signaling by SCF-KIT"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1839117">
<property type="pathway name" value="Signaling by cytosolic FGFR1 fusion mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-186763">
<property type="pathway name" value="Downstream signal transduction"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-877300">
<molecule id="P42224-1"/>
<property type="pathway name" value="Interferon gamma signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-877312">
<molecule id="P42224-1"/>
<property type="pathway name" value="Regulation of IFNG signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8854691">
<property type="pathway name" value="Interleukin-20 family signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939902">
<property type="pathway name" value="Regulation of RUNX2 expression and activity"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8984722">
<property type="pathway name" value="Interleukin-35 Signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8985947">
<property type="pathway name" value="Interleukin-9 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9013508">
<property type="pathway name" value="NOTCH3 Intracellular Domain Regulates Transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020956">
<property type="pathway name" value="Interleukin-27 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020958">
<property type="pathway name" value="Interleukin-21 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-909733">
<property type="pathway name" value="Interferon alpha/beta signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912694">
<property type="pathway name" value="Regulation of IFNA signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9673767">
<property type="pathway name" value="Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9673770">
<property type="pathway name" value="Signaling by PDGFRA extracellular domain mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-982772">
<property type="pathway name" value="Growth hormone receptor signaling"/>
</dbReference>
<dbReference type="SignaLink" id="P42224"/>
<dbReference type="SIGNOR" id="P42224"/>
<dbReference type="BioGRID-ORCS" id="6772">
<property type="hits" value="14 hits in 899 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="STAT1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P42224"/>
<dbReference type="GeneWiki" id="STAT1"/>
<dbReference type="GenomeRNAi" id="6772"/>
<dbReference type="Pharos" id="P42224">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P42224"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="P42224">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000115415">
<property type="expression patterns" value="Expressed in epithelium of bronchus and 244 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P42224">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P42224">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0030425">
<property type="term" value="C:dendrite"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031730">
<property type="term" value="F:CCR5 chemokine receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003690">
<property type="term" value="F:double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035035">
<property type="term" value="F:histone acetyltransferase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042393">
<property type="term" value="F:histone binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0035257">
<property type="term" value="F:nuclear hormone receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990841">
<property type="term" value="F:promoter-specific chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051721">
<property type="term" value="F:protein phosphatase 2A binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070491">
<property type="term" value="F:repressing transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000979">
<property type="term" value="F:RNA polymerase II core promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005164">
<property type="term" value="F:tumor necrosis factor receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044389">
<property type="term" value="F:ubiquitin-like protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008015">
<property type="term" value="P:blood circulation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032869">
<property type="term" value="P:cellular response to insulin stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035458">
<property type="term" value="P:cellular response to interferon-beta"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071346">
<property type="term" value="P:cellular response to interferon-gamma"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071407">
<property type="term" value="P:cellular response to organic cyclic compound"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006952">
<property type="term" value="P:defense response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060333">
<property type="term" value="P:interferon-gamma-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0038114">
<property type="term" value="P:interleukin-21-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070106">
<property type="term" value="P:interleukin-27-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070757">
<property type="term" value="P:interleukin-35-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070102">
<property type="term" value="P:interleukin-6-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038113">
<property type="term" value="P:interleukin-9-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010742">
<property type="term" value="P:macrophage derived foam cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072162">
<property type="term" value="P:metanephric mesenchymal cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072136">
<property type="term" value="P:metanephric mesenchymal cell proliferation involved in metanephros development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046725">
<property type="term" value="P:negative regulation by virus of viral protein levels in host cell"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0016525">
<property type="term" value="P:negative regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001937">
<property type="term" value="P:negative regulation of endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043124">
<property type="term" value="P:negative regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003340">
<property type="term" value="P:negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072308">
<property type="term" value="P:negative regulation of metanephric nephron tubule epithelial cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002230">
<property type="term" value="P:positive regulation of defense response to virus by host"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045648">
<property type="term" value="P:positive regulation of erythrocyte differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032727">
<property type="term" value="P:positive regulation of interferon-alpha production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002053">
<property type="term" value="P:positive regulation of mesenchymal cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051770">
<property type="term" value="P:positive regulation of nitric-oxide synthase biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048661">
<property type="term" value="P:positive regulation of smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007221">
<property type="term" value="P:positive regulation of transcription of Notch receptor target"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007259">
<property type="term" value="P:receptor signaling pathway via JAK-STAT"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060334">
<property type="term" value="P:regulation of interferon-gamma-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0061326">
<property type="term" value="P:renal tubule development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051591">
<property type="term" value="P:response to cAMP"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034097">
<property type="term" value="P:response to cytokine"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042542">
<property type="term" value="P:response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035456">
<property type="term" value="P:response to interferon-beta"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009612">
<property type="term" value="P:response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007584">
<property type="term" value="P:response to nutrient"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043434">
<property type="term" value="P:response to peptide hormone"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033209">
<property type="term" value="P:tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060337">
<property type="term" value="P:type I interferon signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd10372">
<property type="entry name" value="SH2_STAT1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="DisProt" id="DP00962"/>
<dbReference type="Gene3D" id="1.10.532.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.8.1200">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.630">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00046"/>
<dbReference type="InterPro" id="IPR008967">
<property type="entry name" value="p53-like_TF_DNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001217">
<property type="entry name" value="STAT"/>
</dbReference>
<dbReference type="InterPro" id="IPR038295">
<property type="entry name" value="STAT1_C_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR035859">
<property type="entry name" value="STAT1_SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR022752">
<property type="entry name" value="STAT1_TAZ2-bd_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR036535">
<property type="entry name" value="STAT_N_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013800">
<property type="entry name" value="STAT_TF_alpha"/>
</dbReference>
<dbReference type="InterPro" id="IPR015988">
<property type="entry name" value="STAT_TF_coiled-coil"/>
</dbReference>
<dbReference type="InterPro" id="IPR013801">
<property type="entry name" value="STAT_TF_DNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR012345">
<property type="entry name" value="STAT_TF_DNA-bd_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR013799">
<property type="entry name" value="STAT_TF_prot_interaction"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11801">
<property type="entry name" value="PTHR11801"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12162">
<property type="entry name" value="STAT1_TAZ2bind"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01017">
<property type="entry name" value="STAT_alpha"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02864">
<property type="entry name" value="STAT_bind"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02865">
<property type="entry name" value="STAT_int"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00964">
<property type="entry name" value="STAT_int"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47655">
<property type="entry name" value="SSF47655"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48092">
<property type="entry name" value="SSF48092"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49417">
<property type="entry name" value="SSF49417"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0013">ADP-ribosylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0051">Antiviral defense</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="9">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Signal transducer and activator of transcription 1-alpha/beta" id="PRO_0000182410">
<location>
<begin position="2"/>
<end position="750"/>
</location>
</feature>
<feature type="domain" description="SH2" evidence="14">
<location>
<begin position="573"/>
<end position="670"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="48">
<location>
<begin position="136"/>
<end position="317"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="9">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine" evidence="43">
<location>
<position position="114"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine" evidence="43">
<location>
<position position="175"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine" evidence="43">
<location>
<position position="296"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine" evidence="43">
<location>
<position position="366"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine" evidence="43">
<location>
<position position="525"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine" evidence="43">
<location>
<position position="637"/>
</location>
</feature>
<feature type="modified residue" description="ADP-ribosyl glutamic acid; by PARP14" evidence="42">
<location>
<position position="657"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine" evidence="43">
<location>
<position position="665"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by JAK1, JAK2 or TYK2" evidence="27 30 32 35 40 42 43 45">
<location>
<position position="701"/>
</location>
</feature>
<feature type="modified residue" description="ADP-ribosyl glutamic acid; by PARP14" evidence="42">
<location>
<position position="705"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKE" evidence="35">
<location>
<position position="708"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK14" evidence="5 6 7 8 10 22 28 32 35 40 44">
<location>
<position position="727"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKE" evidence="13">
<location>
<position position="745"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="11">
<location>
<position position="703"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="12">
<location>
<position position="703"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Beta." id="VSP_006282" evidence="51 52">
<location>
<begin position="713"/>
<end position="750"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34255470." id="VAR_034521">
<original>I</original>
<variation>T</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; gain of function mutation associated with increased STAT1 phosphorylation due to impaired nuclear dephosphorylation; dbSNP:rs387906764." id="VAR_065934" evidence="34 38">
<original>D</original>
<variation>G</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; dbSNP:rs387906767." id="VAR_065935" evidence="34">
<original>D</original>
<variation>H</variation>
<location>
<position position="165"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; dbSNP:rs387906766." id="VAR_065936" evidence="34">
<original>Y</original>
<variation>N</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; dbSNP:rs387906763." id="VAR_065937" evidence="34">
<original>C</original>
<variation>R</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; gain of function; increases transactivation activity in response to IFNG; dbSNP:rs587777628." id="VAR_075494" evidence="38">
<original>N</original>
<variation>K</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31B; not deleterious in terms of most STAT1 functions; causes abnormal splicing out of exon 8 from most mRNAs thereby decreasing protein levels by approximately 70%; dbSNP:rs587776870." id="VAR_065815" evidence="31">
<original>K</original>
<variation>N</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C." id="VAR_065938" evidence="34">
<original>M</original>
<variation>I</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; dbSNP:rs387906762." id="VAR_065939" evidence="34">
<original>M</original>
<variation>V</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; dbSNP:rs387906759." id="VAR_065940" evidence="33 34">
<original>A</original>
<variation>V</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; dbSNP:rs387906768." id="VAR_065941" evidence="34">
<original>Q</original>
<variation>P</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; gain of function; increases STAT1 phosphorylation due to impaired nuclear dephosphorylation; increases transactivation activity in response to IFNG; dbSNP:rs387906760." id="VAR_065942" evidence="34 38">
<original>R</original>
<variation>Q</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; gain of function; increases phosphorylation in response to IFNG, IFNA and IL27 due to a loss of dephosphorylation; dbSNP:rs387906758." id="VAR_065943" evidence="33 34 38">
<original>R</original>
<variation>W</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; gain of function; increases phosphorylation in response to IFNG and IFNA due to a loss of dephosphorylation; dbSNP:rs863223398." id="VAR_075495" evidence="39">
<original>K</original>
<variation>E</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; gain of function; increases transactivation activity in response to IFNG; dbSNP:rs587777629." id="VAR_075496" evidence="38">
<original>Q</original>
<variation>R</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; dbSNP:rs387906761." id="VAR_065944" evidence="34">
<original>K</original>
<variation>I</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; dbSNP:rs387906765." id="VAR_065945" evidence="34">
<original>T</original>
<variation>A</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; gain of function; increases basal STAT1 phosphorylation levels which are 10-20 fold higher than controls after IFNG stimulation." id="VAR_075497" evidence="41">
<original>K</original>
<variation>N</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31A; affects the DNA-binding activity of the protein; dbSNP:rs137852680." id="VAR_065816" evidence="25">
<original>E</original>
<variation>Q</variation>
<location>
<position position="320"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; gain of function; increases phosphorylation in response to IFNG and IFNA due to a loss of dephosphorylation; dbSNP:rs796065052." id="VAR_075498" evidence="39">
<original>G</original>
<variation>D</variation>
<location>
<position position="384"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31C; gain of function; increases phosphorylation in response to IFNG, IFNA and IL27 due to a loss of dephosphorylation; dbSNP:rs587777630." id="VAR_075499" evidence="38 39">
<original>T</original>
<variation>M</variation>
<location>
<position position="385"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31A; affects the DNA-binding activity of the protein; dbSNP:rs137852679." id="VAR_065817" evidence="25">
<original>Q</original>
<variation>H</variation>
<location>
<position position="463"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_036001" evidence="26">
<original>P</original>
<variation>A</variation>
<location>
<position position="491"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31B; found in an infant who died of a viral-like illness associated with complete STAT1 deficiency; dbSNP:rs137852678." id="VAR_018265" evidence="18">
<original>L</original>
<variation>P</variation>
<location>
<position position="600"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31A; affects both phosphorylation and DNA-binding activity; results in impaired STAT1-mediated cellular response to IFN-gamma and interleukin-27; dbSNP:rs587777705." id="VAR_068713" evidence="37">
<original>K</original>
<variation>E</variation>
<location>
<position position="637"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31A; impairs tyrosine phosphorylation; results in impaired STAT1-mediated cellular response to IFN-gamma and interleukin-27; dbSNP:rs587777704." id="VAR_068714" evidence="37">
<original>K</original>
<variation>R</variation>
<location>
<position position="673"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31B; disrupts transactivation activity in response to IFNG." id="VAR_075500" evidence="38">
<original>Y</original>
<variation>C</variation>
<location>
<position position="701"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD31A; loss of GAF and ISGF3 activation; impairs the nuclear accumulation of GAF but not of ISGF3 in heterozygous cells stimulated by IFNs; affects phosphorylation of the protein; dbSNP:rs137852677." id="VAR_018266" evidence="17 25">
<original>L</original>
<variation>S</variation>
<location>
<position position="706"/>
</location>
</feature>
<feature type="mutagenesis site" description="Sumoylated." evidence="19">
<original>K</original>
<variation>R</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on IFN-alpha-induced STAT1 phosphorylation and nuclear translocation." evidence="43">
<original>K</original>
<variation>A</variation>
<location>
<position position="114"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on IFN-alpha-induced STAT1 phosphorylation and nuclear translocation." evidence="43">
<original>K</original>
<variation>A</variation>
<location>
<position position="175"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on IFN-alpha-induced STAT1 phosphorylation and nuclear translocation." evidence="43">
<original>K</original>
<variation>A</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on IFN-alpha-induced STAT1 phosphorylation and nuclear translocation." evidence="43">
<original>K</original>
<variation>A</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced IFN-alpha-induced STAT1 phosphorylation and nuclear translocation. Does not affect ability to homodimerize." evidence="43">
<original>K</original>
<variation>A</variation>
<location>
<position position="525"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on IFN-alpha-induced STAT1 phosphorylation and nuclear translocation." evidence="43">
<original>KK</original>
<variation>AA</variation>
<location>
<begin position="636"/>
<end position="637"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhances STAT1 nuclear translocation and interferon (IFN)-stimulated gene (ISG) expression in response to IFN-beta stimulation. Reduces viral load in infected cultured cells." evidence="40">
<original>AEN</original>
<variation>CEC</variation>
<location>
<begin position="656"/>
<end position="658"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ADP-ribosylation and increased Tyr-701 phosphorylation; when associated with Q-705." evidence="42">
<original>E</original>
<variation>Q</variation>
<location>
<position position="657"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on IFN-alpha-induced STAT1 phosphorylation and nuclear translocation." evidence="43">
<original>K</original>
<variation>A</variation>
<location>
<position position="665"/>
</location>
</feature>
<feature type="mutagenesis site" description="Not phosphorylated at S-708 upon IFNB induction." evidence="28 35">
<original>Y</original>
<variation>E</variation>
<location>
<position position="701"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on basal sumoylation. Enhances sumoylation in the presence of MAPK stimulation. Phosphorylated at S-708 upon IFNB induction." evidence="28 35">
<original>Y</original>
<variation>F</variation>
<location>
<position position="701"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes sumoylation by SUMO1. Increased IFN-gamma-mediated transactivation." evidence="19 20">
<original>K</original>
<variation>R</variation>
<location>
<position position="703"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ADP-ribosylation and increased Tyr-701 phosphorylation; when associated with Q-657." evidence="42">
<original>E</original>
<variation>Q</variation>
<location>
<position position="705"/>
</location>
</feature>
<feature type="mutagenesis site" description="Phosphorylated at Y-701 upon IFNB induction." evidence="35">
<original>S</original>
<variation>A</variation>
<location>
<position position="708"/>
</location>
</feature>
<feature type="mutagenesis site" description="Not phosphorylated at Y-701 upon IFNB induction." evidence="35">
<original>S</original>
<variation>D</variation>
<location>
<position position="708"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased transcriptional activation. No effect on basal sumoylation. No enhancement of sumoylation on MAPK stimulation. No PRKCD-induced apoptosis. Upon IFNB induction, phosphorylated at Y-701 but not at S-708." evidence="22 28 35">
<original>S</original>
<variation>A</variation>
<location>
<position position="727"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in enhancement of MAPK-induced sumoylation. Basal interaction with PIAS1. Interaction with PIAS1 increased on MAPK stimulation." evidence="22 28 35">
<original>S</original>
<variation>D</variation>
<location>
<position position="727"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in enhancement of MAPK-induced sumoylation." evidence="22 28 35">
<original>S</original>
<variation>E</variation>
<location>
<position position="727"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; ADA59516." ref="2" evidence="53">
<original>A</original>
<variation>T</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAF85293." ref="4" evidence="53">
<original>S</original>
<variation>G</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; CAH18430." ref="5" evidence="53">
<original>Q</original>
<variation>R</variation>
<location>
<position position="718"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="3"/>
<end position="7"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="12"/>
<end position="21"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="23"/>
<end position="26"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="28"/>
<end position="33"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="35"/>
<end position="40"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="43"/>
<end position="46"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="50"/>
<end position="73"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="77"/>
<end position="94"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="99"/>
<end position="120"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="121"/>
<end position="125"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="137"/>
<end position="179"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="189"/>
<end position="192"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="193"/>
<end position="195"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="198"/>
<end position="247"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="257"/>
<end position="286"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="293"/>
<end position="316"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="317"/>
<end position="321"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="334"/>
<end position="336"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="339"/>
<end position="347"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="352"/>
<end position="354"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="355"/>
<end position="357"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="359"/>
<end position="365"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="370"/>
<end position="373"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="374"/>
<end position="376"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="380"/>
<end position="382"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="386"/>
<end position="389"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="391"/>
<end position="395"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="396"/>
<end position="398"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="399"/>
<end position="408"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="421"/>
<end position="425"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="433"/>
<end position="441"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="444"/>
<end position="451"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="455"/>
<end position="460"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="461"/>
<end position="463"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="464"/>
<end position="477"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="486"/>
<end position="488"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="495"/>
<end position="509"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="516"/>
<end position="526"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="539"/>
<end position="543"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="550"/>
<end position="552"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="554"/>
<end position="568"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="570"/>
<end position="574"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="584"/>
<end position="590"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="591"/>
<end position="593"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="601"/>
<end position="603"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="612"/>
<end position="616"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="621"/>
<end position="624"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="627"/>
<end position="631"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="636"/>
<end position="640"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="644"/>
<end position="649"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="657"/>
<end position="659"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="673"/>
<end position="677"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="678"/>
<end position="680"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="728"/>
<end position="738"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="739"/>
<end position="742"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="743"/>
<end position="745"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="746"/>
<end position="748"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1BF5"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1YVL"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KA6"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3WWT"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P42225"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11278462"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11442634"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11452125"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12590259"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12764129"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12855578"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15140960"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15322115"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15825084"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16139798"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16934001"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17561467"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17897103"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18721752"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19088846"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20841510"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21135090"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21714643"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21727188"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22065572"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22383882"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22573496"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23709754"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25288569"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26479788"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26514428"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27796300"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28753426"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7543024"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7657660"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8605877"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9121453"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9630226"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9724754"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9989503"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000303">
<source ref="6"/>
</evidence>
<evidence key="53" type="ECO:0000305"/>
<evidence key="54" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="29858569"/>
</source>
</evidence>
<sequence length="750" mass="87335" checksum="054A813522364BA6" modified="1997-11-01" version="2">MSQWYELQQLDSKFLEQVHQLYDDSFPMEIRQYLAQWLEKQDWEHAANDVSFATIRFHDLLSQLDDQYSRFSLENNFLLQHNIRKSKRNLQDNFQEDPIQMSMIIYSCLKEERKILENAQRFNQAQSGNIQSTVMLDKQKELDSKVRNVKDKVMCIEHEIKSLEDLQDEYDFKCKTLQNREHETNGVAKSDQKQEQLLLKKMYLMLDNKRKEVVHKIIELLNVTELTQNALINDELVEWKRRQQSACIGGPPNACLDQLQNWFTIVAESLQQVRQQLKKLEELEQKYTYEHDPITKNKQVLWDRTFSLFQQLIQSSFVVERQPCMPTHPQRPLVLKTGVQFTVKLRLLVKLQELNYNLKVKVLFDKDVNERNTVKGFRKFNILGTHTKVMNMEESTNGSLAAEFRHLQLKEQKNAGTRTNEGPLIVTEELHSLSFETQLCQPGLVIDLETTSLPVVVISNVSQLPSGWASILWYNMLVAEPRNLSFFLTPPCARWAQLSEVLSWQFSSVTKRGLNVDQLNMLGEKLLGPNASPDGLIPWTRFCKENINDKNFPFWLWIESILELIKKHLLPLWNDGCIMGFISKERERALLKDQQPGTFLLRFSESSREGAITFTWVERSQNGGEPDFHAVEPYTKKELSAVTFPDIIRNYKVMAAENIPENPLKYLYPNIDKDHAFGKYYSRPKEAPEPMELDGPKGTGYIKTELISVSEVHPSRLQTTDNLLPMSPEEFDEVSRIVGSVEFDSMMNTV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

